Objective: Screening for molecular markers of lung cancer proteins to find protein markers that can diagnose and predict the prognosis of lung cancer. Methods: Eighty patients with NSCLC diagnosed in the Fourth Hospital of Xi'an from August 2014 to July 2019 and undergoing lung resection were selected, IHC was used to detect the positive rate of MCM2, MCM5, MCM6, MCM7, KIAA1522 and KIAA0317, to explore the clinical value of combined detection of multiple proteins in the diagnosis and prognosis prediction of NSCLC. Results: The positive rates of MCM2, MCM5, MCM6, MCM7, KIAA1522 and KIAA0317 in lung cancer tissues were significantly higher than normal tissues adjacent to cancer (P<0.05), of which MCM6, MCM7 and KIAA1522 were more than 50 %. In the joint detection of lung cancer tissues, there was no statistically significant difference in the combined protein positive rate of NSCLC patients of different genders, different ages, types and stages (P>0.05), and the protein positive rate was more than 80%; MCM7 high expression was lower than low expression or not The expressed cases significantly increased the patient's risk of death (P=0.000). Males (P=0.031), patients with stage III to IV (P<0.001), and poor differentiation (P=0.012) are also the poor prognostic factors of patients. Multivariate regression analysis shows that MCM7 is an independent predictor (P=0.000), which has a significant correlation with the survival of patients and has a certain predictive effect on prognosis. Conclusion: MCL6, MCM7 and KIAA1522 are highly expressed in lung cancer tissues of NSCLC patients. The combined detection of the three has high accuracy, sensitivity and specificity for the detection of NSCLC. The high level of MCM7 expression indicates poor prognosis of lung cancer patients. [ABSTRACT FROM AUTHOR]